CIK 0001494891 · Non-accelerated filer<br>Smaller reporting company
Sensus Healthcare, Inc.
Sign in to watch- Ticker
- SRTS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 271647271
- Phone
- 561-922-5808
- Business address
- 851 BROKEN SOUND PARKWAY NW, SUITE 215, BOCA RATON, FL, 33487
- Former names
- Sensus Healthcare, LLC
- Open-market buys, last 90 days
- $563,538
- in 5 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$563,538. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 70 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-31 | Rampolla Javier CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −3,935 | $3.03 | $12K | 44,179 |
| 2023-05-11 | Heinrich John Director | Purchase | +10,000 | $2.86 | $29K | 79,940 |
| 2023-05-10 | Sardano Joseph C CHIEF EXECUTIVE OFFICER | Purchase | +7,925 | $3.00 | $24K | 1,155,293 |
| 2023-05-09 | Sardano Joseph C CHIEF EXECUTIVE OFFICER | Purchase | +17,075 | $2.99 | $51K | 1,147,368 |
| 2023-05-09 | O'Rear Samuel Director | Purchase | +17,564 | $3.00 | $53K | 143,570 |
| 2023-05-08 | O'Rear Samuel Director | Purchase | +2,436 | $2.95 | $7K | 126,006 |
| 2023-05-08 | Sardano Michael PRESIDENT AND GENERAL COUNSEL | Purchase | +1,000 | $3.00 | $3K | 56,774 |
| 2023-02-01 | Rampolla Javier CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −742 | $8.84 | $7K | 48,114 |
| 2023-01-26 | Sardano Michael PRESIDENT AND GENERAL COUNSEL | Grant or award | +10,000 | 59,519 | ||
| 2023-01-26 | Sardano Michael PRESIDENT AND GENERAL COUNSEL | Shares withheld for taxes | −3,745 | $8.96 | $34K | 55,774 |
| 2022-09-13 | Sardano Michael PRESIDENT AND GENERAL COUNSEL | Option exercise | +5,000 | $5.55 | $28K | 54,519 |
| 2022-09-13 | Sardano Michael PRESIDENT AND GENERAL COUNSEL | Sale | −5,000 | $14.13 | $71K | 49,519 |
| 2022-09-07 | Sardano Joseph C Chief Executive Officer | Sale | −15,794 | $12.58 | $199K | 1,130,293 |
| 2022-09-06 | Sardano Joseph C Chief Executive Officer | Sale | −15,794 | $12.56 | $198K | 1,146,087 |
| 2022-09-02 | Sardano Joseph C Chief Executive Officer | Sale | −10,000 | $12.42 | $124K | 1,161,881 |
| 2022-08-11 | Sardano Joseph C CHIEF EXECUTIVE OFFICER | Sale | −28,999 | $14.21 | $412K | 1,171,881 |
| 2022-08-10 | Sardano Joseph C CHIEF EXECUTIVE OFFICER | Sale | −93,320 | $14.16 | $1.3M | 1,200,880 |
| 2022-08-10 | O'Rear Samuel Director | Sale | −39,978 | $14.26 | $570K | 123,570 |
| 2022-08-09 | Sardano Joseph C CHIEF EXECUTIVE OFFICER | Sale | −36,093 | $13.97 | $504K | 1,294,200 |
| 2022-08-09 | O'Rear Samuel Director | Sale | −10,022 | $13.96 | $140K | 163,548 |
Page 3 of 8 · 149 trades